Why training pharmaceutical regulatory professionals is key to improving health in Africa
WHO estimates that 1 in every 10 medicines in developing countries is substandard or falsified. Poor-quality medicines, anything ranging from amoxicillin to antimalarials, can fail to treat the ailment intended, result in continued illness or even death, and contribute to the development of antimicrobial resistance. By providing specialized and practical training in quality management systems, good manufacturing practices, and quality control procedures, an international effort in Africa is building local capacity to identify and recall substandard products.
Please read the article from Devex.